secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2025-10-14T23:59:59+00:00
Accession:  0001193125-25-239015
Event type: debt
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm closes $131M debt financing; issues 9% convertible notes, waives defaults
--------------------------------------------------------------------------------

- Borrowed $12.5M under amended credit agreement; issued $15M 2028 and $103.5M 2029 convertible notes at 9%.
- Specified defaults under existing credit agreement waived via Oct 7, 2025 First Amendment.
- As of Oct 14, 2025, common shares outstanding: 15,926,939.
- Financing includes warrants and pre-funded warrants; previously announced on Oct 8, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312525239015/0001193125-25-239015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312525239015/d81116d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-239015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer